Quachmore Pty Ltd

Status: Registered
Australian Company Number: 118449568
Australian Business Number: 43118449568
Address: 1 20 Tranmere St Drummoyne NSW 2047 (business name: Garnet Medical)
Registration date: 2006-02-21
Type: Australian proprietary company
Class: Limited by Shares
Subclass: Proprietary other
last updated

Description

Quachmore Pty Ltd is a limited by shares, Australian proprietary company. This corporation was registered on 2006-02-21 and was issued with the 118449568 ACN. Its Australian Business Number is 43118449568. Since 2016-04-28, the company is headquartered in NSW, post code 2047. The previous headquarters were located in NSW 2047 (from 2014-09-12 to 2016-04-28), NSW 2047 (from 2009-11-03 to 2014-09-12), and NSW 2141 (from 2006-02-22 to 2009-11-03). Quachmore Pty Ltd was registered for the GST on 2006-02-21. The company has also used 3 business names, namely Garnet Medical from 2014-08-07, Sigvaris Online from 2014-05-14 to 2016-06-02 and The Medicines Review Company from 2010-06-16 to 2022-08-07. The above data comes from the ABN database which was updated on 2022-08-07. We found 1 trademark that mention this company.

Details for ABN 43118449568

Type: Australian Private Company

ABN Status

Status From To
Active 2006-02-21 current

Main Name

Name From To
Quachmore Pty Ltd 2006-02-21 current

Business Names

Name From To
Garnet Medical 2014-08-07 current
Sigvaris Online 2014-05-14 2016-06-02
The Medicines Review Company 2010-06-16 2022-08-07

Main Location

Location From To
NSW 2047 2016-04-28 current
NSW 2047 2014-09-12 2016-04-28
NSW 2047 2009-11-03 2014-09-12
NSW 2141 2006-02-22 2009-11-03
NSW 2141 2006-02-21 2006-02-22

Goods & Services Tax (GST)

Status From To
Registered 2006-02-21 current

Advertisements

Business names details

Garnet Medical

Status registered
Registration date 2014-08-07
Renewal date 2017-08-07
Address for service of documents PO BOX 180 Drummoyne NSW 1470 Australia
Principal place of business 1 20 Tranmere St Drummoyne NSW 2047
Debtor representative not applicable
Notified successor not applicable

Sigvaris Online

Status registered
Registration date 2014-05-14
Renewal date 2016-06-16
Address for service of documents PO BOX 180 Drummoyne NSW 1470 Australia
Principal place of business 1 20 Tranmere St Drummoyne NSW 2047
Debtor representative not applicable
Notified successor not applicable

The Medicines Review Company

Status registered
Registration date 2010-06-16
Renewal date 2016-06-16
Address for service of documents PO BOX 180 Drummoyne NSW 1470 Australia
Principal place of business 1 20 Tranmere St Drummoyne NSW 2047
Debtor representative not applicable
Notified successor not applicable
Former identifier BN98508279
Former state territory NSW

Advertisements

Company Trademarks

Trademark number: 1327723

General information:
Lodgement date: 2009-10-25
Live or dead: Live
CPI status: Never Registered
Status: AFS Indexing Approved
Mark code: Trade Mark
Trademark type: Word
Court orders: No
Revocation of the acceptance: No
Goods and services assistance: Yes
Lodgement type: AFS
Descriptive: Medreview Company
NICE class code: 44
NICE occ number: 1
NICE description text: Services For The Preparation Of Medical Reports
Applicant information:
Suburb name: Drummoyne
Postcode: 2047
Australian state code: NSW
Country code: AU

Find company

Location

2024 © aubiz.net - ABN Lookup, ACN, ABR, ABN Search. All rights reserved.
Contact us: info@aubiz.net
Terms of Use and Privacy Policy

Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2024 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2024, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.